Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation.

Zhenxiang Li, Leilei Jiang, Hua Bai, Zhijie Wang, Jun Zhao, Jianchun Duan, Xiaodan Yang, Tongtong An, Jie Wang, Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma. Thoracic Cancer. ,vol. 6, pp. 269- 274 ,(2015) , 10.1111/1759-7714.12177

Oliver Gautschi, Julie Milia, Bastien Cabarrou, Marie-Virginia Bluthgen, Benjamin Besse, Egbert F Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schuler, Alessandra Curioni-Fontecedro, Benjamin Huret, Mallorie Kerjouan, Sebastian Michels, Georg Pall, Sacha Rothschild, Gerald Schmid-Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières, None, Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort Journal of Thoracic Oncology. ,vol. 10, pp. 1451- 1457 ,(2015) , 10.1097/JTO.0000000000000625

Gavin M. Wright, Hongdo Do, Jonathan Weiss, Naveed Z. Alam, Vivek Rathi, Marzena Walkiewicz, Thomas John, Prudence A. Russell, Alexander Dobrovic, Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine Oncotarget. ,vol. 5, pp. 2107- 2115 ,(2014) , 10.18632/ONCOTARGET.1840

Rafael Rosell, Santiago Viteri, Miguel Angel Molina, José Miguel Sánchez-Torres, BRAF mutant non-small cell lung cancer and treatment with BRAF inhibitors Translational lung cancer research. ,vol. 2, pp. 244- 250 ,(2013) , 10.3978/J.ISSN.2218-6751.2013.04.01

David M. Hyman, Igor Puzanov, Vivek Subbiah, Jason E. Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S. Raje, Eli L. Diamond, Antoine Hollebecque, Radj Gervais, Maria Elena Elez-Fernandez, Antoine Italiano, Ralf-Dieter Hofheinz, Manuel Hidalgo, Emily Chan, Martin Schuler, Susan Frances Lasserre, Martina Makrutzki, Florin Sirzen, Maria Luisa Veronese, Josep Tabernero, José Baselga, Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations The New England Journal of Medicine. ,vol. 373, pp. 726- 736 ,(2015) , 10.1056/NEJMOA1502309

Liza C. Villaruz, Mark A. Socinski, Shira Abberbock, Lynne D. Berry, Bruce E. Johnson, David J. Kwiatkowski, A. John Iafrate, Marileila Varella-Garcia, Wilbur A. Franklin, D. Ross Camidge, Lecia V. Sequist, Eric B. Haura, Mark Ladanyi, Brenda F. Kurland, Kelly Kugler, John D. Minna, Paul A. Bunn, Mark G. Kris, Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium Cancer. ,vol. 121, pp. 448- 456 ,(2015) , 10.1002/CNCR.29042

Hong Yang, Brian Higgins, Kenneth Kolinsky, Kathryn Packman, Zenaida Go, Raman Iyer, Stanley Kolis, Sylvia Zhao, Richard Lee, Joseph F. Grippo, Kathleen Schostack, Mary Ellen Simcox, David Heimbrook, Gideon Bollag, Fei Su, RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models Cancer Research. ,vol. 70, pp. 5518- 5527 ,(2010) , 10.1158/0008-5472.CAN-10-0646

Anya M. Litvak, Paul K. Paik, Kaitlin M. Woo, Camelia S. Sima, Matthew D. Hellmann, Maria E. Arcila, Marc Ladanyi, Charles M. Rudin, Mark G. Kris, Gregory J. Riely, Clinical characteristics and course of 63 patients with BRAF mutant lung cancers. Journal of Thoracic Oncology. ,vol. 9, pp. 1669- 1674 ,(2014) , 10.1097/JTO.0000000000000344

Hong Qin, Feng Pan, Jianjun Li, Xiaoli Zhang, Houjie Liang, Zhihua Ruan, Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0111475

Dong Chen, Li-Qun Zhang, Jun-Fu Huang, Kai Liu, Zheng-Ran Chuai, Zhao Yang, Yun-Xia Wang, Da-Chuan Shi, Qian Liu, Qing Huang, Wei-Ling Fu, BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis PLoS ONE. ,vol. 9, pp. e101354- ,(2014) , 10.1371/JOURNAL.PONE.0101354